Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells

被引:182
作者
Zhao, L
Guo, QL
You, QD
Wu, ZQ
Gu, HY
机构
[1] China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Peoples R China
关键词
gambogic acid; MGC-803; apoptosis; inhibition rate; bax; bcl-2;
D O I
10.1248/bpb.27.998
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The selective induction of apoptosis of gambogic acid (GA) on MGC-803 cells and its probable molecular mechanism were studied. GA greatly inhibited (24, 48, 72 h) the growth of MGC-803 cells (by MTT); the IC50 value was 0.96 mug/ml at 48 h. Meanwhile, no influence was observed on body weight, number of WBC (white blood cells) in blood or karyote in marrow of rats after GA was injected intravenously. We conclude that GA does not affect normal cells, but that it can induce apoptosis in tumor cells selectively and there were marked morphological changes. A great quantity of apoptotic cells and increasing G(2)/M phase cells were observed by flow cytometry, and a significant percentage of early apoptotic cells were observed by Annexin-V/PI double staining assay. The increase of bax gene and the decrease of bcl-2 gene expressions were detected by immunohistochemistry. Activation of bax and suppression of bcl-2 may contribute to the apoptosis mechanism.
引用
收藏
页码:998 / 1003
页数:6
相关论文
共 20 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   Apoptosis [J].
Afford, S ;
Randhawa, S .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2000, 53 (02) :55-63
[3]  
[Anonymous], 1982, J JIANGXI MED COLL, V3, P1
[4]   The Bcl-2 protein family [J].
Antonsson, B ;
Martinou, JC .
EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) :50-57
[5]  
Chen R. C., 1980, J NANJING AGR COLLEG, V2, P1
[6]  
CHEN YS, 2002, TUMOR MOL CELL BIO 9, V1, P141
[7]  
DONG C, 1988, CHIN B PHARM, V23, P89
[8]  
Guo QingLong, 2004, Chinese Journal of Natural Medicines, V2, P106
[9]  
KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO
[10]  
2-J